Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 55

Results For "PAS"

920 News Found

Akums partners with Leiutis and Biophore for developing products for multiple therapies
News | December 01, 2022

Akums partners with Leiutis and Biophore for developing products for multiple therapies

The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas


CPhI and P-MEC India sees participation of over 1500 exhibitors
News | November 29, 2022

CPhI and P-MEC India sees participation of over 1500 exhibitors

40,000 visitors and representatives of more than 80 countries set to visit the show


Azelis inaugurates pharmaceuticals & healthcare lab for APAC in India
News | November 28, 2022

Azelis inaugurates pharmaceuticals & healthcare lab for APAC in India

The pharma laboratory is fully equipped with all the machinery needed to support formulation development, resolve technical challenges, and provide customer demonstrations


Sai Life Sciences appoints Stephen Hermitage as VP, CMC
People | November 28, 2022

Sai Life Sciences appoints Stephen Hermitage as VP, CMC

Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.


Early detection of lung cancer vital to combat rising mortality rate, says GlobalData
News | November 27, 2022

Early detection of lung cancer vital to combat rising mortality rate, says GlobalData

The only definitive way to diagnose and stage lung cancers is through biopsies


Laurus Labs takes stake in Ethan Energy India
News | November 25, 2022

Laurus Labs takes stake in Ethan Energy India

This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant


Alembic receives USFDA final approval for Nifedipine Extended-Release Tablets
Drug Approval | November 22, 2022

Alembic receives USFDA final approval for Nifedipine Extended-Release Tablets

Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022


CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore pharma market by 2030
News | November 17, 2022

CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore pharma market by 2030

The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees


Cadila recognized for its contribution to leprosy treatment
News | November 16, 2022

Cadila recognized for its contribution to leprosy treatment

Cadila Pharmaceuticals was felicitated during the plenary session of the 21st International Leprosy Congress


SMS Pharma revenue down 9%
News | November 15, 2022

SMS Pharma revenue down 9%

Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market